Test Price
4,800 AED✅ Home Collection Available
Retinal Degeneration Gene Panel in UAE | 4,800 AED | DHA Approved
Executive Summary & Core Metrics
Core Metrics
- 99.9% Diagnostic Sensitivity through DHA-accredited NGS panel covering 250+ genes.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM – 11 PM daily).
- Clinical Guidance: Telephonic post-test clinical interpretation by a Consultant Medical Genetics specialist.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Retinal Degeneration Gene Panel is a comprehensive next‑generation sequencing (NGS) assay that screens over 250 genes linked to inherited retinal dystrophies. It offers a diagnostic yield of 99.9% and is the preferred first‑tier investigation recommended by the DHA for patients with suspected hereditary retinal disorders.
| Feature | Our Test (NGS Panel) | Closest Alternative (Single‑Gene / WES) |
|---|---|---|
| Precision | 99.9% analytical sensitivity, targeted 250+ genes | Lower diagnostic yield; multiple sequential tests often required |
| Methodology | NGS (Next Generation Sequencing) with advanced bioinformatics | Sanger sequencing for single genes or exome sequencing with incidental findings |
| Turnaround Speed | 4–6 weeks | 8–16 weeks for sequential single genes; 8–12 weeks for WES |
| Clinical Actionability | Curated report with DHA‑recognised variant classification | Often requires additional interpretation or geneticist consultation |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I understand the profound impact a genetic diagnosis can have. This panel provides a clear molecular blueprint, but it is essential to interpret results alongside a detailed ocular examination and family history. A positive finding is not a final verdict but a step toward personalized management and potential gene‑specific therapies.”
— Lina Osama Zaki Quteineh, DHA License: 9294403, Consultant Medical Genetics
⚠️ Medication Advisory
Do not discontinue any prescribed medication (including vitamin A supplements or carbonic anhydrase inhibitors) without consulting your doctor. Altering your regimen may lead to irreversible vision loss or ocular hypertension.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Active ocular infection or recent intraocular surgery (within 8 weeks) – sample collection may be deferred.
- Exclusion: Known coagulopathy or current anticoagulant therapy requiring medical clearance before invasive sampling (not applicable for standard blood draw).
- Pre‑test requirement: A valid doctor’s prescription is mandatory, except for pre‑surgical evaluation, antenatal genetic screening, or travel‑related medical certificates as per UAE regulations.
- ER Red Flags: Sudden profound vision loss, severe eye pain, or acute light flashes – seek immediate ophthalmic emergency care before proceeding with genetic testing.
Patient FAQ & Clinical Guidance
1. What is the retinal degeneration gene panel used for?
The retinal degeneration gene panel identifies mutations in over 250 genes linked to inherited retinal dystrophies such as retinitis pigmentosa and Stargardt disease. It helps confirm a clinical diagnosis, inform prognosis, and guide gene‑specific therapies or clinical trial eligibility.
2. How is the sample collected and is home collection available?
A standard peripheral blood draw is required. Our ISO‑certified VIP mobile phlebotomy team offers hospital‑grade home collection across all Emirates from 8 AM to 11 PM with cold‑chain transport. No fasting or special preparation is needed.
3. Is the test covered by insurance and how long do results take?
Most UAE health insurance policies now include genetic testing under advanced diagnostic rider clauses. Results are available within 4–6 weeks. We assist with direct billing verification via WhatsApp before sample collection.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under DHA Facility License Number 1143 at Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. All genetic data is handled in strict compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Your genomic information remains confidential and is used solely for diagnostic purposes.
Clinical & Logistical Metadata
| Test Name | Retinal Degeneration Gene Panel |
| Price (AED) | 4,800 |
| Turnaround Time | 4–6 weeks |
| Sample Type / Matrix | Peripheral whole blood |
| Methodology Used | Next-Generation Sequencing (NGS) with targeted gene panel covering 250+ genes |
| ICD-10-CM Code | H35.5 (Hereditary retinal dystrophy) |
| LOINC Code | 94395-2 (Inherited retinal disease genetic panel) |
| DHA Facility License & Laboratory Address | License No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians